“…Platelet surface receptor GPIIbIIIa plays a key role in platelet aggregation, hemostasis, and thrombosis. 30,31 However, as shown in Table 1, data from a murine model of immune thrombocytopenia demonstrate that GPIIbIIIa may be directly involved in PL-Apo, since strong thrombocytopenia induced by injection into mice of anti-GPIIb antibody, resulting in a reduction of platelet count by approximately 75%, was associated with increase in ΔΨm depolarization, caspase-3 activation, and PS exposure. 32 Furthermore, clinical studies have shown that pediatric acute immune thrombocytopenia (often associated with GPIIbIIIa autoantibodies) was also associated with increased ΔΨm depolarization, caspase-3, -9, -8 activation, PS exposure, and MP formation.…”